Molpiravir 200mg

Indication

- Treatment of mild to moderate COVID-19 in adults - For patients at increased risk of progressing to severe COVID-19 - Antiviral therapy

Ingredients

• Molnupiravir 200 mg

Direction

Usual adult dose is 800 mg (four 200 mg capsules) taken orally every 12 hours for 5 days. Start as soon as possible after diagnosis and within 5 days of symptom onset.

Side effects

• Diarrhea
• Nausea
• Dizziness
• Headache

Precautions

• Not recommended during pregnancy
• use effective contraception during and after treatment
• Not recommended for breastfeeding
• Not authorized for use under 18 years of age
• Not a substitute for COVID
• 19 vaccination